6.250GBp-2.34%Mkt Cap: 2.98M $P/E: —1d ago
Feedback plc provides software and systems to those working in the field of medical imaging. The company's products include Bleepa, an image-based communication platform for frontline clinicians; CareLocker, a patient-ce…
Industry Peers
Health Information Services$32.06BUSDP/E 35.0
$13.38BUSDP/E 88.5
$9.62BUSD
$8.27BUSDP/E 37.0
$6.65BUSD
$5.65BUSD
$4.44BUSDP/E 34.6
$3.43BUSDP/E 160.1
$2.24BUSD
$2.14BUSDP/E 106.8
$1.71BUSD
$1.41BUSD
$1.17BUSD
$1.13BUSD
$1.06BUSDP/E 52.0
$874.42MUSDP/E Infinity
$845.49MUSDP/E 43.2
$672.72MUSDP/E 68.1
$637.77MUSD
$581.77MUSDP/E 27.4
$584.81MUSD
$552.27MUSDP/E 13.1
$524.39MUSD
$516.62MUSD
$494.46MUSDP/E 56.3
$460.71MUSDP/E 25.8
$446.52MUSDP/E 25.4
$393.58MUSDP/E 90.5
$368.70MUSDP/E 45.6
$321.33MUSD
$230.81MUSDP/E 14.1
$224.12MUSDP/E 18.2
$217.63MUSD
$182.96MUSD
$156.35MUSDP/E 39.4
$168.48MUSD
$148.67MUSDP/E 29.6
$123.72MUSDP/E Infinity
$124.79MUSDP/E 18.5
$113.48MUSDP/E 25.4
$99.01MUSDP/E 17.9
$86.66MUSD
$65.63MUSDP/E 11.3
$62.29MUSDP/E 22.6
$57.34MUSD
$47.87MUSDP/E 57.6
$49.50MUSD
$40.55MUSDP/E 38.7
$39.14MUSD
$31.93MUSD
$26.93MUSDP/E 26.0
$22.91MUSDP/E 54.8
$20.17MUSD
$18.43MUSD
$12.99MUSD
$13.69MUSD
$12.35MUSD
$11.72MUSD
$9.78MUSDP/E 15.1
$6.67MUSD
$6.50MUSD
$5.63MUSD
$4.88MUSD
$3.78MUSDP/E Infinity
$3.83MUSDP/E 0.0
$3.40MUSD
$2.70MUSD
$2.16MUSDP/E Infinity
$693.4KUSD
$548.9KUSDP/E 0.0
$282.6KUSD
—
CRY
GraniteShares YieldBOOST CRCL ETF—
—
EYES
Corgi Data & Surveillance ETF—P/E 30.8
—
Indicators:|
Key Statistics
Company
Market Cap2.98M $
Enterprise Value-1.18M $
Revenue (TTM)923.50K $
Gross Profit846.36K $
Net Income (TTM)-7.95M $
Revenue/Share0.0207 USD
Last Price6.250 GBp
Fiscal Year EndMay 2025
MR QuarterNov 2025
Employees29
CountryGB
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.25
PEG—
EV/EBITDA0.27
EV/Revenue-1.28
P/S3.22
P/B0.61
EPS (TTM)-0.16
EPS (Forward)-0.26
52W Range
6.2001% of range15.00
52W High15.00 GBp
52W Low6.200 GBp
Profitability
Gross Margin87.92%
Oper. Margin-432.69%
EBITDA Margin0.00%
Profit Margin-826.25%
ROE-118.70%
ROA-108.35%
Growth
Revenue Growth-8.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.07M $
CapEx (TTM)906.32K $
FCF Margin-231.57%
FCF Yield-71.85%
Net Debt-4.16M $
Net Debt/EBITDA0.96
Balance Sheet
Debt/Equity—
Current Ratio10.34
Quick Ratio10.34
Book Value/Sh0.1020 GBp
Cash/Share0.0870 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJul 10, 1995
Pay Date—
Splits
Last Split1:200
Split DateOct 14, 2022
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)60.00 GBp
Upside (mean)+860.0%
Target Range60.00 GBp – 60.00 GBp
# Analysts1
Ownership
Shares Out.43.81M
Float33.52M
Insiders5.49%
Institutions51.18%
Technical
SMA 507.749 (-19.3%)
SMA 2009.975 (-37.3%)
Beta-0.09
S&P 52W Chg20.25%
Avg Vol (30d)99.91K
Avg Vol (10d)119.49K
Technical Indicators
RSI (14)15.9
MACD-0.4497
MACD Signal-0.4575
MACD Hist.+0.0079
BB Upper7.707 GBp
BB Middle6.950 GBp
BB Lower6.193 GBp
BB Width21.78%
ATR (14)0.2457 GBp
Vol Ratio (20d)4.45x